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Abstract
There is some interest in how mammalian oocytes respond to different types of DNA damage because of the increasing
expectation of fertility preservation in women undergoing chemotherapy. Double strand breaks (DSBs) induced by ionizing
radiation and agents such as neocarzinostatin (NCS), and interstrand crosslinks (ICLs) induced by alkylating agents such as
mitomycin C (MMC), are toxic DNA lesions that need to be repaired for cell survival. Here we examined the effects of NCS
and MMC treatment on oocytes collected from antral follicles in mice, because potentially such oocytes are readily collected
from ovaries and do not need to be in vitro grown to achieve meiotic competency. We found that oocytes were sensitive to
NCS, such that this ionizing radiation mimetic blocked meiosis I and caused fragmented DNA. In contrast, MMC had no
impact on the completion of either meiosis I or II, even at extremely high doses. However, oocytes treated with MMC did
show c-H2AX foci and following their in vitro maturation and parthenogenetic activation the development of the
subsequent embryos was severely compromised. Addition of MMC to 1-cell embryos caused a similarly poor level of
development, demonstrating oocytes have eventual sensitivity to this ICL-inducing agent but this does not occur during
their meiotic division. In oocytes, the association of Fanconi Anemia protein, FANCD2, with sites of ICL lesions was not
apparent until entry into the embryonic cell cycle. In conclusion, meiotic maturation of oocytes is sensitive to DSBs but not
ICLs. The ability of oocytes to tolerate severe ICL damage and yet complete meiosis, means that this type of DNA lesion goes
unrepaired in oocytes but impacts on subsequent embryo quality.
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Introduction
Mammalian oocytes spend most of their lives at the dictyate
stage of meiosis I, in so-called Germinal Vesicle (GV) arrest.
Meiotic resumption is only initiated under a hormonal cue in the
hours preceding ovulation. This unique type of cell arrest however
presents problems in maintaining oocyte health over the months,
and dependent on species, possibly decades of cell cycle arrest. In
part, this problem is solved by a 2-way communication of growth
factors with surrounding granulosa cells within the follicle [1,2,3].
Despite this somatic support, however, female aging still results in
a drop in oocyte quality. Most notably, this is observed by a rise in
mis-segregation of homologous chromosomes in meiosis I [4,5],
possibly caused by a loss in the cohesive proteins holding them
together [6,7,8]. In oocytes, cohesin complexes get loaded onto
replicating chromosomes during fetal life but cannot be repaired in
the adult [9,10]. As such with age, homologous chromosomes
loose attachment with each other.
Given that oocytes spend the majority of their long life in GV
arrest, it is important to resolve what their capacity is to detect and
respond to damage done to the DNA itself, as opposed to the
proteins holding chromosomes together. Especially considering the
increasing expectation for fertility preservation in females of
reproductive age and younger, undergoing cancer treatment
[11,12]. GV oocytes contained with primordial follicles, which
represent the longest stage of meiotic arrest, die in response to
double strand breaks (DSBs) induced by ionising radiation (IR)
[13,14], probably through a c-Abl-p63 mediated apoptotic
pathway, which appears to be most active in non-growing follicles
[15,16,17]. GV bovine oocytes contained within growing or fully
mature follicles have also been suggested to undergo cell death in
response to IR [18], and similarly meiosis stalls in pig oocytes from
mature follicle that are exposed to UV-C light [19].
Interstrand crosslinks (ICLs) are extremely toxic lesions, distinct
from DSBs, formed between 2 strands of DNA. Without repair,
they prevent DNA replication [20]. Around 10 ICLs are believed
to be formed per cell per day in somatic cells [21]. Agents such as
mitomycin C (MMC) that chemically induce ICLs, are an effective
chemotherapeutic agent to help prevent proliferation of cancer
cells and are a useful tool to study the consequences of ICLs on cell
function. The Fanconi Anemia (FA) pathway is thought to play an
important part in ICL detection and repair [22,23,24], and its
activation recruits FANCD2 and FANCI together to form the so-
called ID complex, at discrete nuclear foci of DNA damage. Some
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members of the FA pathway, including the ID complex, load onto
site of ICLs independent of replication [25,26], suggesting that
FANCD2, as part of the ID complex, is involved at an early step in
the sensing of an ICL.
Given the importance of the FA pathway in ICL DNA repair,
and possibly more generally in metabolic-induced DNA damage
through production of acetaldehydes [27] and oxidative stress
[28,29], here we decided to examine the timing of ICL DNA
repair and FA activation in mouse GV oocytes and preimplan-
tation embryos. Specifically, we wanted to examine if oocytes have
the capacity to sense DNA damage induced by MMC, as assessed
by the targeting of FANCD2 to site of ICLs. We thought it
important to examine from this time onwards because clinically
these are the stages used for assisted fertility treatments and it
would be useful to understand how these oocytes respond to
increased ICL DNA damage. The sensitivity of mouse oocytes to
DNA damage brought about by MMC-induced ICLs was
compared to that of DSBs caused by the widely used ionizing
radiation mimetic neocarzinostatin (NCS) [30,31,32,33].
Materials and Methods
HeLa Cell Culture
HeLa cells (ATCC, Cat No. CCL-2) were cultured in DMEM
Low Glucose (Invitrogen) supplemented with 10% FCS (Invitro-
gen) and 1% penicillin-streptomycin (Invitrogen) at 37uC in 5%
CO2. A double thymidine block was performed as described
previously [34].
Ethics Statement
Mice were used in strict accordance with the Australian Code of
Practice for the Care and Use of Animals for Scientific Purposes.
This protocol was approved by the University of Newcastle
Animal Care and Ethics Committee (Ethics approval number A-
2008-1079).
Oocyte Collection and Culture
GV oocytes and mature eggs were collected from hormonally
primed F1 hybrid mice (C57BL6 females 6 CBA males) as
described previously [35,36]. Milrinone (1 mM) was added to
maintain arrest [37]. GV oocytes were allowed to mature in vitro
for 14 hours in M2 media.
Embryo Activation and Culture
Mature eggs were parthenogenetically activated in Ca2+-free
KSOM medium supplemented with 10 mM SrCl2 for 5 hours
[38]. 1 mg/ml of cytochalasin D was added to diploidise embryos.
1-cell embryos were treated at 5 hours post-activation with MMC
for 4 hours. Embryo culture was in KSOMaa [39] at 37uC in 5%
CO2. Pronuclei, 2-cell embryos and blastocysts were scored at 9,
24 and 120 hours post-activation respectively.
Cell, Oocyte and Embryo Treatments
In HeLa cells, 250 ng/ml MMC was added immediately after
thymidine release for 4 hours and cells were fixed either at 4 or
7 hours post release. In oocytes, MMC at specified concentrations
were added immediately after milrinone washout for 4 hours and
cells were fixed either after maturation or at 9 hours post
activation. NCS at specified concentrations was added immedi-
ately after milrinone washout for 1 hour, and oocytes were fixed
following in vitro maturation. In embryos, MMC was added at
5 hours post-activation for 4 hours and embryos were fixed at
9 hours post-activation.
Immunofluorescence
HeLa cells, cultured on coverslips, were fixed in 4% parafor-
maldehyde in PHEM/PVP then permeabilised with 2% Triton X-
100, 30 minutes each at room temperature. Oocytes and embryos
were fixed and permeabilised as described previously [40].
Immunofluorescence was performed as described previously [41]
using a monoclonal anti-tubulin antibody (1:200, Molecular
Probes) and/or polyclonal anti-FANCD2 antibody (1:500, Abcam)
or anti-cH2AX antibody (1:100, Abcam) supplemented with 1%
BSA and 0.2% Tween 20 for 1–2 hours at room temperature.
Secondary antibodies, conjugated with Alexa488 or Alexa633
(1:1000, Molecular Probes), were used for detection by incubating
cells for 1 hour at room temperature. Oocytes or HeLa cells were
briefly stained with Hoechst (20 mg/ml) or propidium iodide
(10 mg/ml) to label chromatin before mounting on glass slides with
Citifluor (Citifluor Ltd, UK).
Imaging and Data analysis
Confocal microscopy was performed using an Olympus FV1000
equipped with a 60x/1.2 NA UPLSAPO oil immersion objective
lens. Z-stacks were captured with an interval of 1–2 mm. Analysis
was performed with FV10-ASW 2.0 Viewer software (Olympus).
For foci counting, images were converted to 8-bit gray images and
foci were counted using ImageJ software (NIH, Bethesda, USA)
following setting their threshold to 1.7 times the average
background. This value of 1.7 was used because it most closely
matched foci counted by users in initial somatic cell experiments.
Statistical analysis
All statistical analysis was performed using Graphpad Prism 5.0
software. Dichotomous data, such as polar body extrusion rates,
were pooled from repeated observations. Comparison between
groups was made using Fisher’s exact test. FANCD2 foci data
were pooled and means between 2 groups compared by Student’s
t-test or by ANOVA for multiple groups. The number of repeats is
stated in each figure legend.
Results
Neocarzinostatin blocks oocyte maturation and
fragments DNA
Mouse GV stage oocytes collected from antral follicles were
treated with the ionizing radiation mimetic NCS for a period of
1 hour before in vitro maturation. They were allowed to mature
through to metaphase II (metII) and first polar body extrusion
(PB1) rates assessed. Maturation rates were normally ,80%,
however significant inhibition of meiosis I was observed at NCS
concentrations of 0.3 mg/ml and greater (Fig 1A). Furthermore,
the rate of PB1 extrusion was exceedingly low at ,7% following a
1 hour incubation of GV oocytes with 1 mg/ml NCS. Examina-
tion of the DNA from meiotically arrested oocytes treated with
NCS showed condensed and varying levels of fragmented
chromatin, with fragmentation high in a number of oocytes
(Fig 1B). The effects of NCS appeared dose dependent, with 35%
of oocytes having such fragmentation at 0.1 mg/ml, rising to 100%
at higher doses (1–3 mg/ml); none of the untreated oocytes
displayed such abnormalities (Fig 1C).
Ataxia Telangiectasia Mutated (ATM) and ATM-and Rad3-
related (ATR), are major regulators of DNA damage, and
phosphorylate the histone H2AX, generating the epitope recog-
nised by anti- cH2AX antibodies [42,43,44]. We therefore
immunoprobed GV oocytes, and found very significant amounts
of cH2AX foci associated with chromatin in all oocytes following
Effects of DNA Damage in Mouse Oocytes
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incubation with NCS; in contrast, all untreated oocytes did not
stain positive for cH2AX (Fig 1D, E).
Mitomycin C-induced ICLs do not block completion of
meiosis I or II in oocytes
In order to begin to understand the effect that ICLs have on
meiosis, GV oocytes were in vitro cultured with MMC added for
the first 4 hours. PB1 extrusion rates were determined 8 hours
later. MMC had no effect on the ability of oocytes to undergo
meiotic maturation, with polar body rates high at about 80% for
all groups (Fig 2A). The highest concentration of MMC tested was
20 mg/ml, which is ,1000-fold higher than reported to be
effective on mitotic cells [45] and this had no statistical significance
on first polar body extrusion rate compared to controls (86% vs
77%, p= 0.13, n.s. Fig 2A).
The effect that MMC has on nuclear maturation of oocytes may
be subtler than simply blocking the process of PB1 extrusion.
Therefore, the chromatin of metII eggs matured from GV oocytes
that had been treated with MMC were examined for meiotic
spindle integrity. However, we observed no difference in the
meiotic spindles from MMC-treated eggs, with small rates of
chromosomal misalignment for all groups (Fig 2B, C). Finally, we
examined their ability to complete meiosis and become 1-cell
embryos by parthenogenetic activation with Sr2+-containing
medium. The rates of second polar body (PB2) extrusion and
pronucleus (PN) formation rates were found to be unaffected by
previous MMC addition (Fig 2D, E). From all these observations
we can conclude that the induction of ICLs during the first 4 hours
of maturation has no inhibitory effect on the ability of oocyte to
complete its meiotic divisions and become a 1-cell embryo.
Mitomycin C-induced ICLs inhibit embryo development
Next, we wanted to establish if the induction of ICLs at the GV
stage has an impact on subsequent embryo development. To
examine this, GV oocytes were treated with the same two doses
used above, 3 or 20 mg/ml MMC for the first 4 hours of
maturation, in vitro matured, parthenogenetically activated, and
preimplantation embryo development to the blastocyst stage
Figure 1. Neocarzinostatin, an ionizing radiation mimetic, fragments DNA and blocks meiosis in oocytes. (A) First polar body (PB1)
extrusion rates following maturation of oocytes treated with NCS. (B) Chromatin in oocytes from (A); (i) depicting a typical metaphase II egg that was
not treated with NCS, (ii, iii) meiotic arrest caused by NCS with varying levels of fragmentation. White dotted line represents egg and polar body
outlines. (C) Percentage of oocytes treated with or without NCS that display fragmented DNA. (D) Nuclear staining of cH2AX in GV oocytes with or
without NCS treatment; asterisks is at center of nucleolus. (E) Percentage of cH2AX positive oocytes treated with or without NCS. (A, C, E) Pooled data
from 2 replicates. In parentheses, total number of oocytes examined. (A) Different letters denote significant difference, p,0.05 (Fisher’s exact test). (B,
D) Scale bar, 10 mm.
doi:10.1371/journal.pone.0043875.g001
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assessed (Fig 3A). For GV oocytes cultured without MMC, we
observed nearly 60% rates of development to the blastocyst stage.
However, less than 7% of embryos developed past the morula
stage if they had been pre-treated with either of the two MMC
concentrations (not shown). In order to observe any development
to the blastocyst stage, the concentration of MMC needed to be
lowered. GV oocytes treated with 0.1 mg/ml MMC were found to
have a significantly reduced blastocyst formation rate compared to
controls (57% vs 44%, p= 0.03, x2 Fisher’s exact test) and 0.3 mg/
ml MMC reduced development to below 20% (Fig 3B).
Finally we thought it would be interesting to determine if
exposure of GV oocytes to MMC was in any way more or less
detrimental than if 1-cell embryos were incubated with this
chemotherapeutic agent. In both groups, GV oocytes were in vitro
matured, parthenogenetically activated and cultured to the
blastocyst stage. However, for those 1-cell embryos treated with
MMC, its incubation followed pronucleus formation at 5 hours
after parthenogenetic activation (Fig 3A). With the two MMC
doses examined, we observed no significant difference in the rate
of blastocyst formation (Fig 3B) between those exposed at the GV
stage and those exposed as 1-cell embryos.
In summary, the above data suggest that induction of ICLs in
GV stage oocytes has no impact on the completion of meiosis but
does impact on subsequent development to the blastocyst stage. It
was interesting that even at doses 200-fold higher than that able to
impair embryogenesis the process of meiosis was unaffected. The
observation that oocytes treated at the GV stage with MMC had
severely impacted embryo development following their in vitro
maturation (Fig 3) also highlights the fact that any lack of effect of
MMC during maturation was not simply a consequence of GV
oocytes being impermeant to this drug. In fact, GV oocytes and 1-
cell embryos are likely to be equally permeant to this ICL-inducing
agent, given rates of embryo development were affected to the
same degree when MMC was added to them. Thus, as judged by
the inhibition of blastocyst formation, the developmental time
point for MMC addition appears unimportant as similar inhibition
rates were observed whether MMC was added at the GV stage or
in 1-cell embryos.
ICL induced FANCD2 nuclear foci in somatic cells but not
in oocytes
ICLs, induced for example by MMC, are repaired by the FA
pathway. It has been reported that in dividing somatic cells,
FANCD2 localises to sites of such DNA damage during S-phase in
the form of discrete nuclear foci [46,47,48], which remain on any
sites of unrepaired damage during the subsequent cell cycle
[49,50]. Using synchronised HeLa cells, we confirmed this pattern
of localisation (Fig 4A) and furthermore showed that FANCD2
foci increased nearly threefold following addition of 0.25 mg/ml
MMC (Fig 4B–D). These observations are consistent with the
ability of MMC to induce ICLs, and the involvement of the FA
pathway in their repair.
In contrast to HeLa cells, GV oocytes showed little or no
FANCD2 nuclear staining even following addition of 20 mg/ml
MMC, which is 80 times the concentration used on HeLa cells
(Fig 5A). This suggests that FANCD2 is not recruited to sites of
DNA damage during GV arrest. Such a finding could simply be
interpreted in terms of an absence of this FA pathway protein in
Figure 2. Interstrand crosslinking has no effect on completion of meiosis in oocytes. (A) First polar body (PB1) extrusion rates in oocyes
treated with MMC after milrinone washout. (B, C) Meiotic spindles from mature metaphase II stage eggs obtained in (A) were imaged (B) and the
sister chromatids on the spindle classified as aligned or mis-aligned (C). Arrow, indicates a non-aligned chromosome. Scale bar, 10 mm. (D, E) Rates of
second polar body extrusion (D) and pronucleus formation (E) in parthenogenetically activated eggs following addition of MMC to GV stage oocytes
that were then in vitro matured. (A, C, D, E) Pooled data from between 4 to 5 replicates; in parentheses, number of eggs examined; n.s., p.0.05
(Fisher’s exact test).
doi:10.1371/journal.pone.0043875.g002
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oocytes, however FANCD2 immunostaining, with the same
antibody used to label HeLa cells, was seen on both spindle
microtubules and at spindle poles during both metaphase I and II
(Fig 5B and 5C). Interestingly, its location was unaffected by prior
treatment at the GV stage with MMC (Fig 5B and 5C).
To determine if GV oocytes can detect these ICLs, cH2AX
immunostaining was performed. Without MMC treatment GV
oocytes show little or no cH2AX foci, however, when GV oocytes
were treated with MMC, discrete cH2AX foci were formed on
chromatin (Fig 6A). Counting these foci revealed a 50-fold
increase following addition of 20 mg/ml MMC (2 foci/oocyte vs
117 foci/oocyte; Fig 6B). Coupled with the FANCD2 localisation
experiments, these observations indicate that oocytes can detect
the ICLs lesions but the FA pathway is not recruited in response at
the GV stage.
FANCD2 foci in 1-cell embryos
As FANCD2 foci did not form during meiosis, we investigated if
the FA pathway was only activated once embryogenesis was
initiated. Parthenogenetically activated 1-cell embryos were
challenged with or without MMC following pronucleus formation
and the number of nuclear FANCD2 foci counted using the same
protocol established for HeLa cells (Fig 4D). In the absence of
MMC, FANCD2 was present as discrete foci on the pronuclei of
the 1-cell embryo (Fig 7A). Further, the number of foci increased
2.5-fold, (110 nuclear foci/embryo vs 272 nuclear foci/embryo,
p = 0.005; Fig 7B) following exposure to 3 mg/ml MMC. We note
that this dose had no effect on foci formation when added to GV
oocytes.
Finally, we examined if FANCD2 foci formed at a higher rate
dependent on the time of MMC addition. Previously we had
shown that MMC treatment at either the GV stage or 1-cell
embryo stage both equally impaired embryo development (Fig 3).
As such we anticipated that MMC addition at either the GV or 1-
cell embryo stages would lead to the similar levels of DNA damage
as defined by FANCD2 foci. Indeed, this proved to be the case
with the same numbers of foci present with MMC independent of
the time of addition (Fig 7B).
Discussion
NCS, often used as an ionizing radiation mimetic to induce
DSBs, was observed to be a potent inhibitor of meiotic maturation
in mouse oocytes. Affected oocytes contained condensed and
fragmented chromatin following just one hour exposure to the
drug at the GV stage. The effects of the drug are presumed similar
to IR, and indeed bovine oocytes demonstrate meiotic arrest
following UV–C light exposure [19]. Based on these findings and
those following treatment of whole ovary, we can surmise that
DSBs profoundly affect GV oocytes at all follicular stages of their
development. In primordial follicles it appears to promote loss
through apoptosis, while in oocytes from fully-grown antral
follicles, NCS-induced DSBs are an effective method of blocking
meiotic maturation. The reason for the selective apoptosis in
oocytes from primordial, but not antral follicles may be readily
explained by the loss of TAp63, an oocyte-specific member of the
p53 family essential for apoptosis, from oocytes following follicle
recruitment [15,16,17].
Earlier studies have shown that IR-induced DSBs are detected
in the newly formed 1-cell embryo [51,52]. Mature sperm are
thought to be incapable of identifying and repairing damaged
DNA, and it is therefore left to the zygote formed immediately
following gamete union to perform these tasks [53,54]. The
findings here, of MMC-induced FANCD2 foci in zygotes are
consistent with the notion that DNA repair is active in early
embryos, suggest that both ICLs and DSBs may be repaired at this
point. Given the high rates of oxidative stress thought to be present
in sperm [55,56], the activation of the FA pathway at this time
may of considerable benefit to the successful development of the
embryo.
Women with FA have premature menopause [57], and
consistent with this mouse knockouts for FA pathway members
have a smaller ovarian reserve, which results in infertility later in
life [58,59,60]. This represents the effect of an absent FA pathway
during the mitotic S phases prior to meiosis, resulting in germ cell
hypoplasia [61,62,63]. Indeed early meiotic functions for FA genes
have recently been described also in zebrafish and C. elegans
[64,65]. However, the role of the FA pathway in oocytes, during
later meiosis, has not been extensively investigated. Our data
suggest that by the time oocytes have reached their fully-grown
size and are arrested in the GV stage, then the FA pathway is not
active. cH2AX foci however did form on treatment with MMC,
consistent with previous observations of its recruitment to ICL
sites. The recruitment of cH2AX but not FANCD2 suggests that
although the FA pathway is not active, oocytes still have the
capacity to recognise DNA damage. Such tagging of DNA at the
GV stage may then be useful for its subsequent repair following
egg activation. Instead, development of FANCD2 foci at sites of
DNA damage does not occur until the 1-cell embryo stage. This
increase in foci upon ICL induction indicates an active FA
pathway in embryos. However, when embryos were treated with
Figure 3. Comparable impaired embryo development follow-
ing ICL induction at either GV or 1-embryo stage. (A) Schematic
showing the experimental design. MMC was either added after
milrinone washout or following parthenogenetic activation with Sr2+.
Blastocyst rates were assessed at 120 hours. (B) Blastocyst rates from
those oocytes treated as in (A) with the MMC concentration stated. In
parentheses, number of eggs examined from 3 pooled replicates;
different letters denote significantly difference (p,0.05; Fisher’s exact
test).
doi:10.1371/journal.pone.0043875.g003
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MMC, this led to decreased blastocyst rates even at low
concentrations. This sensitivity to MMC in spite of increased
FANCD2 foci should not imply an absence of ICL repair, given
decreased cell survival is also observed in HeLa cells treated with
similar MMC dosages [66], and these cells are well recognised to
have a robust FA pathway [50,67,68]. Instead, the decreased
survival of HeLa cells and the lowered blastocyst rates are both
likely due to the severe DNA damage inflicted by MMC that
overwhelms the repair process.
The lack of any effect in meiosis I and II upon MMC treatment,
as well as the consequential defective blastocyst development were
not necessarily unexpected. GV oocytes lack any gene transcrip-
tion and do not replicate their DNA, which possibly explains the
tolerance to high doses of MMC. In contrast, embryos need to
undergo S-phases for proper growth, and it is likely that during
these embryonic S-phases the FA pathway is full engaged. The GV
stage, although being a time in which DNA damage is induced but
not repaired, was not however uniquely vulnerable to ICL induced
damage, given embryo development was equally impaired if 1-cell
embryos were challenged with MMC at the same dose and for the
same duration. Consistent with our observations are previous
experiments on synchronised HeLa cells and fibroblasts where it
was predominantly at S-phase that FANCD2 became recruited to
DNA in an unperturbed cell cycle [45] and that in order for cells
Figure 4. Interstrand crosslinking increases FANCD2 nuclear foci in HeLa cells. (A) FANCD2 immunostaining of synchronised HeLa cells in
S-, G2- and M-phase. (B) FANCD2 nuclear foci during S-phase with or without MMC. (C) Nuclear FANCD2 foci counted per cell (mean 6 standard
deviation) from images in (B). In parentheses, total number of cells examined from 2 pooled replicates, *p,0.0001 (t-test). (D) Nuclear foci were
calculated using a software-based approach. Confocal images were converted from 32-bit RGB to an 8-bit gray scale. ImageJ software was used to
interrogate images, identify and count all nuclear foci of greater than 1.7x the mean nuclear background. In the 3 cells depicted the foci are
numbered. (A, B) Scale bar, 10 mm.
doi:10.1371/journal.pone.0043875.g004
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to become MMC sensitive they had to have undergone an S-phase
[69]. However, severe MMC-induced DNA damage results in the
recruitment of the ID complex, which FANCD2 is part of, to all
nuclei irrespective of cell cycle phase [47]. More directly, others
have demonstrated an ability of MMC to recruit the ID complex
to sites of ICLs independent of replication [25,26]. Furthermore,
other studies point to activation of the FA pathway in response to
DNA damage that might not be entirely the same as that induced
Figure 5. FANCD2 association with spindle microtubules and poles but not nuclear foci in oocytes. (A) FANCD2 immunostaining of the
nuclei in GV oocytes with or without previous MMC addition at the concentrations stated. No FANCD2 foci were observed. (B, C) FANCD2
immunostaining of either meiotic spindles in meiosis I (B) or at metaphase II arrest (C). FANCD2 was present on spindle microtubules and poles, and
its localisation was unaffected by MMC addition. Images are representative of at least 10 oocytes from at least two replicates. Scale bar, 10 mm.
doi:10.1371/journal.pone.0043875.g005
Figure 6. Induction of cH2AX foci in GV oocytes following MMC addition. (A) cH2AX immunostaining shown in GV oocytes treated with or
without 20 mg/ml MMC. Scale bar, 10 mm. (B) cH2AX foci (mean 6 standard deviation) counted per oocyte from images in (A). In parentheses, total
number of oocytes examined, pooled from 2 independent experiments. *p,0.0001 (t-test).
doi:10.1371/journal.pone.0043875.g006
Effects of DNA Damage in Mouse Oocytes
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in S-phase [70]. Therefore, the FA pathway is not exclusively S-
phase based and replication dependent.
FANCD2 localisation to the meiosis I and II oocytes spindle and
poles while initially surprising is similar to that reported previously
for BRCA1 [71]. Indeed, these two proteins have been shown
associated in somatic cells to sites of DNA damage [45,46]. Given
their non-chromosomal localisation in maturing oocytes, other
cellular functions beyond DNA repair are possible. BRCA1 has
been implicated in mitotic spindle integrity and function
independent of repair [72,73]. Consistent with a role for BRCA1
in spindle function, knockdown in mouse oocytes leads to spindle
malformations and aneuploidy [71,74]. It remains possible that
FANCD2 has functions outside of DNA repair, and precedence
for this is set by FANCD1 (BRCA2) which: (i) regulates the
stability of BubR1, a member of the Spindle Assembly Checkpoint
(SAC), that sets the timing of anaphase in mitosis [75] and (ii)
regulates cytokinesis by localising to the central spindle formed
during mitotic exit [68,76,77,78]. Given the possibility of a non-
repair function for FANCD2 suggested by its meiotic spindle
association, future studies should therefore be directed, like for
BRCA1, at its potential role in aneuploidy prevention.
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